Susquehanna International Group
ADIL

Susquehanna International Group’s Adial Pharmaceuticals ADIL Stock Holding History

Susquehanna International Group’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-483
Closed -$2.66K – 13076
2025
Q4 		$2.66K Buy
+483
New +$3.91K ﹤0.01% 12119
2024
Q1 		– Sell
-592
Closed -$27.5K – 12057
2023
Q4 		$27.5K Buy
+592
New +$32.4K ﹤0.01% 11898
2023
Q3 		– Sell
-288
Closed -$37.5K – 11924
2023
Q2 		$37.5K Sell
288
-68
-19% -$12.3K ﹤0.01% 11446
2023
Q1 		$77.8K Buy
356
+210
+144% +$50.9K ﹤0.01% 11450
2022
Q4 		$19.4K Buy
+146
New +$25.6K ﹤0.01% 11775
2022
Q3 		– Sell
-159
Closed -$133K – 13067
2022
Q2 		$133K Buy
159
+130
+448% +$118K ﹤0.01% 11173
2022
Q1 		$36K Buy
29
+9
+45% +$12.3K ﹤0.01% 12438
2021
Q4 		$33K Buy
+20
New +$39.4K ﹤0.01% 12712
2020
Q2 		– Sell
-22
Closed -$18K – 10034
2020
Q1 		$18K Buy
+22
New +$23.5K ﹤0.01% 9951

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Susquehanna International Group's ADIL Position: Q1 2026 in Review

Susquehanna International Group sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 483 shares — an estimated $2.66K sold.

Susquehanna International Group first reported a position in ADIL in Q1 2020 and held it in 9 quarters. The position peaked at $133K in Q2 2022. 14 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Susquehanna International Group reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 483 Adial Pharmaceuticals shares in Q1 2026, an estimated $2.66K.
  • Susquehanna International Group first reported a position in Adial Pharmaceuticals in Q1 2020 and held it in 9 quarters.
  • Susquehanna International Group's Adial Pharmaceuticals position peaked at $133K in Q2 2022.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.